Replies to post #6145 on Organovo Holdings, Inc. (ONVO)

[RandolRocketman]

I think a lot depends on how much detail they provide on the contracts we've all been hearing about. If we see a report of a significant jump in revenues, there's no telling how hard this will run up. So, I think anything under $10 this year is cheap and I am, and continue to be, adding to my position at these cheap levels.
The downside risk here is really hard to find. Occasional short attacks might cause the random dip in PPS, but otherwise there's nothing I have been able to find wrong with this company.
The upside is really hard to gauge, given the potential for so many different paths to revenue streams. The management team clearly are doing an outstanding job growing this company to fulfill the dreams they seem to all share.
The science is proven and secured with considerable IP protection in the form of their patent portfolio.
And the future potential is frankly off the charts once they begin printing full sized organs.
Last year, before they listed on the NYSE, I heard estimates of two decades before they could print organs. Earlier this year I read estimates of ten years, and last month I read an article that said six years. I'm betting it will be closer to two years.
So clearly I am long ONVO.

[jdsgungho]

you spent 87,000 dollars on a stock and are asking whens a good time to exit. Personally , i dont think you should have ever bought it, SMH